Hypoxia-inducible factors (HIFs) and biological responses, in hypoxia, inflammation and embryonic vascular development.
Abstract
ABSTRACT
Low oxygen tension (hypoxia) is a major inducer of neovascularisation and evidence emerging has indicated that oxygen tension and hypoxia-inducible factors (HIFs), a family of oxygen-regulated heterodimeric transcription factors, may play important roles in vascular and hematopoietic development. This thesis has focused on studying molecular and cellular mechanisms, by which cells and organisms sense changes in oxygen tension, and how this signal is transduced by HIFs into downstream signalling.
Cells, tissues, and organisms experience reduced oxygen (O2) tension, or hypoxia under both physiologic and pathologic conditions. The total of all signals are integrated in the nucleus of the target cell, activating transcription of genes necessary for modulating cell function. HIF-1 is a key regulator of VEGF mediated angiogenesis, glycolysis and differentiation among a range of cellular responses to hypoxia. HIF-1 is also activated by non-hypoxic stimuli,
like growth factors, hormones and cytokines i.e. IL-1 and TNF-a.
To investigate the possibility to induce HIF under non-hypoxic conditions, we made a construct, denoted the saturating domain (SD), based on a domain of HIF-1a. As hoped for, expression of the SD, saturated degradation of endogenous HIF-1a proteins, resulting in activation of HIF-1 mediated transcription in normoxia. Aggregates of differentiating embryonic stem (ES) cells, denoted embryoid bodies form blood vessels in a manner faithfully recapitulating vascular development and angiogenesis in vivo. By using ES cells lacking HIF-1a or HIF-2a, we show that HIF-1a is required for vascularisation. The related HIF-2a protein plays a role in regulating the number and activity of early endothelial and hematopoietic cells. Peritoneal dialysis (PD) induces fibrosis and angiogenesis in the peritoneal membrane, leading to ultrafiltration failure. The mesenteric-window angiogenesis model was used to study the role of the HIF-system in experimental PD. We showed that PD fluid exposure lead to hypoxia and activation of HIF-1a in various resident and inflammatory cell types. The increased HIF levels, either induced by hypoxia or inflammation, points out different cellular sources of VEGF.
The HIF-system is an interesting target for pharmacological intervention aiming at inhibition of VEGF-mediated angiogenesis in inflammatory disorders (PD) and at stimulation of blood vessel formation in ischemic diseases.
Parts of work
I. Activation of hypoxia-induced transcription in normoxia. (2005) Hägg, M. and Wennström, S. Exp. Cell Res. 306, 180-191 ::doi::10.1016/j.yexcr.2005.01.017 II. Hypoxia-inducible factor-2a (HIF-2a) modulates formation of vascular/hematopoietic progenitors in differentiating embryonic stem cells. *Hägg, M., *Nilsson, I., Carmeliet, P., Claesson-Welsh, L. and Wennström, S. Manuscript. *Authors contributed equally to the manuscript. III. Hypoxia-inducible factor-1a (HIF-1a) activation and hypoxia following catheter implantation and a single peritoneal dialysis dwell. Hägg, M., Cavallini, N. and Braide, M. Manuscript.
Degree
Doctor of Philosophy (Medicine)
University
University of Gothenburg. Sahlgrenska Academy
Institution
Inst of Biomedicine. Dept of Medical Biochemistry and Cell Biology
maria.hagg@anatcell.gu.se
Date
2008-04-21Author
Hägg, Maria
Keywords
Embryonic stem cell, embryoid body, HIF-1a, hypoxia, VEGF, angiogenesis, vasculogenesis, peritoneal dialysis
Publication type
Doctoral thesis
ISBN
978-91-628-7446-9
Language
eng